Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 113,250 | — |
| Research and development | 600,510 | 760,036 |
| Selling, general and administrative | 10M | 4M |
| Operating expenses | 10M | 5M |
| Pre-tax income | −13M | −5M |
| Net income | −13M | −5M |
| Earnings per share | −0.40 | −0.16 |
| Earnings per share, diluted | −0.40 | −0.16 |
| Weighted average shares | 32M | 29M |
| Weighted average shares, diluted | 32M | 29M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6M | 2M | 816,715 | 607,496 | 295,368 | 129,318 | 291,793 | 168,815 |
| Short-term investments | 3M |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | −8M | −2M |
| Depreciation and amortisation | 66,889 | 29,115 |
| Share-based compensation | 3M | 1M |
| Capital expenditure | 495,185 | 38,155 |
| Investing cash flow | −362,081 | −114,655 |
| Financing cash flow | 11M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 2M |
| — |
| — |
| — |
| — |
| — |
| Receivables | — | 4,975 | 4,900 | 89,075 | — | — | — | — |
| Current assets | 9M | 2M | 9M | 8M | 8M | 617,262 | — | — |
| Property, plant and equipment | 679,333 | 514,684 | 152,915 | 126,586 | 91,168 | 95,425 | — | — |
| Total assets | 15M | 11M | 10M | 8M | 8M | 987,788 | — | — |
| Current liabilities | 11M | 7M | 5M | 5M | 2M | 2M | — | — |
| Total liabilities | 13M | 8M | 5M | 5M | 2M | 2M | — | — |
| Equity | 3M | 2M | 5M | 3M | 6M | −983,175 | −765,570 | −1M |
| Shares outstanding | 38M | 34M | 34M | 33M | 30M | 29M | — | — |
| Shares issued | 38M | 34M | 34M | 33M | 30M | 29M | — | — |
| Treasury shares | — | — | 19,700 | 3M | 3M | 0 | — | — |
| 2M |